Association between serum pepsinogen and atherosclerotic cardiovascular disease

Abstract

Background and aim: Serum pepsinogens (PGs) are biomarkers for gastric mucosal damage and have been reported to be associated with atherosclerosis. Its correlation with atherosclerotic cardiovascular disease (ASCVD) is still unknown. This study aimed to explore the association between serum PGs and ASCVD for providing physicians with an integrative picture to make rational plans in the diagnosis and treatment of ASCVD. Methods and results: The concentrations of serum PGs and their distributions between ASCVD and non-ASCVD were compared by non-parametric test, Chi-squared test and Fisher exact test. The correlation between variables was analyzed by Spearman's correlation test. The association of serum PGs with ASCVD was analyzed by the binary logistic regression and two-piecewise linear regression. A total of 8355 recruited cases were eligible for the study. The concentrations of serum PGs were significantly different between the ASCVD and non-ASCVD groups (P Z 0.025, P < 0.001). The lower PGI and PGR levels were significantly correlated with a high risk of ASCVD presence after adjustment for 26 potential covariates. Moreover, there was a linear relationship between the high level of PGII and the high risk of ASCVD [adjusted OR Z 1.16 (1.00, 1.37), P Z 0.07]. A nonlinear relationship of PGI/PGR and ASCVD (P Z 0.08/<0.001) was also revealed. The risk of ASCVD increased with a range of log PGI !2.13 (PGI!131 ng/mL) [adjusted OR Z 4.67 (1.00, 23.17)], and decreased with a range of log PGR !0.22 (1.65) [adjusted OR Z 0.59 (0.48, 0.74), P < 0.001]. Conclusions: Serum PGI and PGR are nonlinearly correlated with ASCVD, while PGII is linearly correlated with ASCVD. Among all PGs, PGR may serve as a reliable biomarker for ASCVD.

Low PGⅡ levels may indicate an increased risk of gastric mucosal intestinal metaplasia in outpatients experiencing stomach discomfort: a retrospective cross-sectional study

“…PGII has the potential to indicate gastric acidity levels and could potentially signify an excess growth of bacteria in the small intestine [11]. Serum PGs are considered biomarkers that indicate damage to the stomach lining and have been linked to atherosclerosis [12]. The reduction in pepsinogen II levels cannot be consistently relied upon as an accurate marker for con rming successful eradication of Hp infection four weeks after completing treatment [13].…”